PATRICIA MACALUSO: Open Payments
NPI 1811751837 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 31 payments from 12 companies in 2025. Trend: 2023 $61 · 2024 $270 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $192 |
| Medtronic, Inc. | 3 | $178 |
| Alnylam Pharmaceuticals Inc. | 3 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Novo Nordisk Inc | 3 | $78 |
| Esperion Therapeutics, Inc. | 3 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Boston Scientific Corporation | 1 | $37 |
| CVRx, Inc. | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $27 |
Products named: LEQVIO, MYCARELINK, ONPATTRO, Wegovy, FARXIGA, NEXLETOL, JARDIANCE, WATCHMAN Access System.
Industry payments across FL — which companies pay providers there.
